How many employees work at Graviti Pharmaceuticals?
Graviti Pharmaceuticals Pvt Ltd. has approximately 802 total employees worldwide as of March 2026, according to Revelio Labs workforce intelligence data. Graviti Pharmaceuticals’s total headcount has grown 42.2% from 564 employees in 2023 to 802 in 2026.
Is Graviti Pharmaceuticals hiring right now?
Yes, Graviti Pharmaceuticals is actively hiring. Graviti Pharmaceuticals had 5 active job postings in 2026, a 0.0% no change from 2025 — see job openings & hiring trends.
About Graviti Pharmaceuticals’s Workforce
Graviti Pharmaceuticals Pvt Ltd. is a Pharmaceuticals company that employs 802 people worldwide as of March 2026. It is the 10th-largest by headcount among its peers. Founded in 2012, the company is headquartered in Hyderabad, India.
Graviti Pharmaceuticals's workforce has grown 42.2% from 2023 to 2026, up 5.2% year over year in 2026. Its workforce is concentrated most in South Asia (100.0%).
Graviti Pharmaceuticals's functional groups are Finance and Operations (51.8%), Engineering (24.8%), and Sales and Marketing (23.4%), with Sales and Marketing growing fastest (up 8.4%). The average salary is $8,645, highest in South Asia at a median of $6,000, up 5.5% year over year in 2026.
Graviti Pharmaceuticals's hiring activity held steady in 2026.
Sourced from Revelio Labs workforce data.
- Headquarters
- Hyderabad, India
- Founded
- 2012
- Industry
- Pharmaceuticals
- Employees
- 802
- YoY
- +5.2% (+103)
As of March 2026
Graviti Pharmaceuticals workforce metrics
Unlock hiring rate, attrition rate, and 12 additional workforce metrics for Graviti Pharmaceuticals. Compare to peers, export the dataset, and access the full quarterly history.
Unlock MetricsGraviti Pharmaceuticals Annual Employee Count (2023-2026)
- Graviti Pharmaceuticals had 802 employees in 2026, a 5.2% increase (+103) from 2025.
- Graviti Pharmaceuticals had 801 employees in 2025, a 6.2% increase (+113) from 2024.
- Graviti Pharmaceuticals had 688 employees in 2024, a 7.2% increase (+106) from 2023.
- Graviti Pharmaceuticals had 582 employees in 2023, a 5.7% increase (+19) from 2022.
Graviti Pharmaceuticals's total workforce has grown from 564 employees in 2023 to 802 in 2026.
Graviti Pharmaceuticals Pvt Ltd. quarterly employee count
| Year | Qtr | Employees | YoY Change | YoY % |
|---|---|---|---|---|
| 2026 | Q1 | 802 | +103 | +5.2% |
| 2025 | Q4 | 801 | +113 | +6.2% |
| 2025 | Q3 | 758 | +91 | +3.6% |
| 2025 | Q2 | 738 | +121 | +5.8% |
| 2025 | Q1 | 699 | +90 | +5.1% |
| 2024 | Q4 | 688 | +106 | +7.2% |
| 2024 | Q3 | 667 | +92 | +11.8% |
| 2024 | Q2 | 617 | +53 | +8.8% |
| 2024 | Q1 | 609 | +48 | +8.3% |
| 2023 | Q4 | 582 | +19 | +5.7% |
| 2023 | Q3 | 575 | +14 | +2.9% |
| 2023 | Q2 | 564 | +26 | +3.5% |
See Graviti Pharmaceuticals's complete headcount history, including quarterly breakdowns.
Get the DataGraviti Pharmaceuticals Employee Count by Region (2026)
South Asia accounts for the largest share of Graviti Pharmaceuticals's global workforce with approximately 100% of total employees.
Graviti Pharmaceuticals employees by region
| Region | Employees | % of Total |
|---|---|---|
| South Asia | 789 | 100.0% |
Drill into city-level data, hiring trends by region, and historic geographic shifts.
Unlock Geographic DataGraviti Pharmaceuticals Employee Count by Department (2026)
Graviti Pharmaceuticals's employee groups are Finance and Operations (51.8%), Engineering (24.8%), and Sales and Marketing (23.4%).
Graviti Pharmaceuticals employees by department
| Department | Employees | % of Total |
|---|---|---|
| Finance and Operations | 412 | 51.8% |
| Engineering | 197 | 24.8% |
| Sales and Marketing | 186 | 23.4% |
Compare Graviti Pharmaceuticals's department mix to industry peers.
See Full DataGraviti Pharmaceuticals Employee Salary by Region (2026)
Graviti Pharmaceuticals's average employee salary is $8,645 globally. Employees in South Asia receive the highest compensation.
Graviti Pharmaceuticals median employee salary by region (USD)
| Region | Median Salary |
|---|---|
| South Asia | $6,000 |
Unlock salary by role, level, and city — and compare to Graviti Pharmaceuticals's industry peers.
Unlock Salary DataGraviti Pharmaceuticals Job Openings and Hiring Trends (2023-2026)
- Graviti Pharmaceuticals had 5 active job postings in 2026, a 0% no change (-2) from 2025.
- Graviti Pharmaceuticals had 7 active job postings in 2025, a 15.4% increase (+1) from 2024.
- Graviti Pharmaceuticals had 6 active job postings in 2024, a 200.0% increase (+6) from 2023.
- Graviti Pharmaceuticals had 0 active job postings in 2023, a 0% no change from 2022.
- Hiring velocity in 2026: 1 new roles/month, down from 3 in 2025 and 3 in 2024.
Graviti Pharmaceuticals's hiring activity held steady in 2026.
Track new postings per month, role-level demand, and hiring velocity vs. peers.
Unlock Hiring DataSimilar Companies
Similar Pharmaceuticals Companies by Employee Count
Frequently Asked Questions About Graviti Pharmaceuticals
- How fast is Graviti Pharmaceuticals growing?
- In 2026, Graviti Pharmaceuticals's headcount grew 5.2% to 802 employees, up from 699 in 2025.
- See the full headcount history
- Where are Graviti Pharmaceuticals employees located?
- Most Graviti Pharmaceuticals employees are based in South Asia (100.0% of headcount).
- Explore where the workforce is based
- What is the average salary at Graviti Pharmaceuticals?
- The average employee salary at Graviti Pharmaceuticals is approximately $8.6k per year.
- Analyze the salary distribution
- How many new job postings does Graviti Pharmaceuticals open per year?
- In Q1 2026, Graviti Pharmaceuticals opened 2 new job postings. In 2025, Graviti Pharmaceuticals opened 41 new job postings — about 3 per month.
- Track hiring trends by role
- When was Graviti Pharmaceuticals founded and where is it headquartered?
- Graviti Pharmaceuticals was founded in 2012 and is headquartered in Hyderabad, India.
- Compare Graviti Pharmaceuticals to industry peers
Speak with a workforce expert about Graviti Pharmaceuticals.
Book a DemoSee something that doesn't look right? Reach out and our team will review it.